Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

172.60
Delayed Data
As of Mar 27
 -0.03 / -0.02%
Today’s Change
86.00
Today|||52-Week Range
172.98
+50.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line87.4M64.2M143.0M-414.9M
 
 
 
 
 
Depreciation15.2M52.2M52.1M226.3M
 
 
 
 
 
Total Other Cash Flow33.6M68.6M47.4M321.1M
 
 
 
 
 
Funds From Operations60.0M177.5M191.0M-110.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-59.1M90.0M-224.8M-114.6M
 
 
 
 
 
Net Cash Flow - Operating Activities119.2M87.6M415.9M4.2M
 
 
 
 
 
 
InvestingDecrease In Investments0.000.00--44.9M
 
 
Capital Expenditures-26.1M-5.4M-6.9M-17.8M
 
 
 
 
 
Net Assets From Acquisitions -362.5M-10.0M0.00-2.5B
 
 
 
 
Net Cash Flow Investing-388.6M-15.4M-6.9M-2.4B
 
 
 
 
 
 
FinancingShort Term Borrowings0.00-138.0K0.000.00
 
 
Long Term Borrowings0.00668.8M0.001.9B
 
 
 
Long Term Debt Reduction-272.0K-156.9M-12.5M-60.3M
 
 
 
 
 
Net Proceeds Stock Sale5.4M107.5M4.2M7.1M
 
 
 
 
 
Common Preferred Redeemed0.00-74.8M0.000.00
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing42.3M11.0M9.7M0.00
 
 
 
 
Other Uses - Financing3.0M169.9M4.0M47.3M
 
 
 
 
 
Net Cash Flow - Financing44.4M385.6M-2.6M1.8B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-111.0K349.0K513.0K-1.2M
 
 
 
 
 
 
Net Change In Cash-225.1M457.8M406.3M-657.3M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account